Free Trial

CenterBook Partners LP Buys 11,142 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Stevanato Group logo with Medical background

Key Points

  • CenterBook Partners LP increased its stake in Stevanato Group S.p.A. by 10.4% during the first quarter, owning a total of 118,065 shares worth approximately $2.4 million at the end of the reporting period.
  • Analysts have a consensus rating of "Moderate Buy" for Stevanato Group, with an average target price of €25.70 ($29.88), indicating positive market sentiment.
  • Stevanato Group's stock has seen a growth of 4.4% recently, with shares opening at €24.11 ($28.03), reflecting a strong performance amid a market cap of $7.3 billion.
  • Looking to export and analyze Stevanato Group data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

CenterBook Partners LP grew its position in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 10.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 118,065 shares of the company's stock after purchasing an additional 11,142 shares during the period. CenterBook Partners LP's holdings in Stevanato Group were worth $2,411,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in STVN. Frontier Capital Management Co. LLC increased its holdings in Stevanato Group by 1,012.0% during the fourth quarter. Frontier Capital Management Co. LLC now owns 1,003,235 shares of the company's stock worth $21,860,000 after buying an additional 913,019 shares during the last quarter. Ranger Investment Management L.P. purchased a new stake in Stevanato Group during the fourth quarter worth about $12,940,000. Thornburg Investment Management Inc. increased its holdings in Stevanato Group by 48.1% during the fourth quarter. Thornburg Investment Management Inc. now owns 1,122,098 shares of the company's stock worth $24,451,000 after buying an additional 364,471 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in Stevanato Group during the fourth quarter worth about $5,754,000. Finally, Jennison Associates LLC increased its holdings in Stevanato Group by 27.9% during the first quarter. Jennison Associates LLC now owns 1,188,057 shares of the company's stock worth $24,260,000 after buying an additional 259,231 shares during the last quarter.

Stevanato Group Price Performance

Shares of STVN stock traded down €0.88 ($1.02) during trading hours on Monday, reaching €22.75 ($26.45). The stock had a trading volume of 126,368 shares, compared to its average volume of 338,187. The stock's fifty day simple moving average is €24.52 and its 200 day simple moving average is €22.44. The company has a current ratio of 1.79, a quick ratio of 1.22 and a debt-to-equity ratio of 0.25. Stevanato Group S.p.A. has a 12 month low of €17.12 ($19.91) and a 12 month high of €28.00 ($32.56). The firm has a market capitalization of $6.89 billion, a PE ratio of 42.13, a PEG ratio of 2.23 and a beta of 0.55.

Analysts Set New Price Targets

A number of analysts recently issued reports on STVN shares. William Blair restated an "outperform" rating on shares of Stevanato Group in a report on Monday, June 30th. Stephens upgraded shares of Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. Two investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Stevanato Group currently has a consensus rating of "Moderate Buy" and an average price target of €25.13 ($29.22).

Check Out Our Latest Analysis on STVN

Stevanato Group Profile

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Articles

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines